~ PEDMARK is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-metastatic Solid Tumors ~ ~ The ...
Please provide your email address to receive an email when new articles are posted on . Children with growth hormone deficiency assigned long-acting recombinant GH therapy experienced an increase in ...
Board-certified subspecialists in the Division of Pediatric Allergy, Asthma and Immunology specialize in the diagnosis and treatment of children with allergic and immunologic diseases. Allergic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback